相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Deprescribing long-term use of benzodiazepines in primary care practice: where to next?
Alexander Sweetman et al.
SLEEP (2023)
Effect of discontinuation of lemborexant following long-term treatment of insomnia disorder: Secondary analysis of a randomized clinical trial
Yoshikazu Takaesu et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2023)
Discontinuing antidepressants: Pearls and pitfalls
Samantha Zwiebel et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2022)
Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials
Emmanuel Mignot et al.
LANCET NEUROLOGY (2022)
Assessment of Suvorexant and Eszopiclone as Alternatives to Benzodiazepines for Treating Insomnia in Patients With Major Depressive Disorder
Yuki Shigetsura et al.
CLINICAL NEUROPHARMACOLOGY (2022)
Epidemiology of Insomnia Prevalence, Course, Risk Factors, and Public Health Burden
Charles M. Morin et al.
SLEEP MEDICINE CLINICS (2022)
The Effects of Insomnia and Sleep Loss on Cardiovascular Disease
Meena S. Khan et al.
SLEEP MEDICINE CLINICS (2022)
Long-term safety and efficacy of daridorexant in patients with insomnia disorder
D. Kunz et al.
SLEEP MEDICINE (2022)
Insomnia
Michael L. Perlis et al.
LANCET (2022)
Drug-Induced Insomnia and Excessive Sleepiness
Ann Van Gastel
SLEEP MEDICINE CLINICS (2022)
Hypnotic Discontinuation in Chronic Insomnia
Jonathan P. Hintze et al.
SLEEP MEDICINE CLINICS (2022)
Quetiapine withdrawal: A systematic review
Katherine Monahan et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2021)
Depressive Symptoms in Comorbid Obstructive Sleep Apnea and Insomnia: An Integrative Review
Bomin Jeon et al.
WESTERN JOURNAL OF NURSING RESEARCH (2021)
Prevalence of and factors associated with acute withdrawal symptoms after 24 weeks of eszopiclone treatment in patients with chronic insomnia: a prospective, interventional study
Yuichi Inoue et al.
BMC PSYCHIATRY (2021)
335 Evaluation of Dose Transition From Zolpidem to Lemborexant Across 14 Weeks: Results From a Multicenter Open-label Pilot Study
Russell Rosenberg et al.
SLEEP (2021)
Long-term effectiveness and safety of lemborexant in adults with insomnia disorder: results from a phase 3 randomized clinical trial
Jane Yardley et al.
SLEEP MEDICINE (2021)
Assessment of Patient-Preferred Language to Achieve Goal-Aligned Deprescribing in Older Adults
Ariel R. Green et al.
JAMA NETWORK OPEN (2021)
Characteristics of patients who were able to switch from benzodiazepine hypnotics to lemborexant
Hidenobu Suzuki et al.
SAGE OPEN MEDICINE (2021)
Melatonin and melatonin agonists as treatments for benzodiazepines and hypnotics withdrawal in patients with primary insomnia. A systematic review
Armando L. Morera-Fumero et al.
DRUG AND ALCOHOL DEPENDENCE (2020)
Efficacy and safety of esmirtazapine in adult outpatients with chronic primary insomnia: a randomized, double-blind placebo-controlled study and open-label extension
Neely Ivgy-May et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2020)
Comparisons Between Successful Versus Unsuccessful Switches From Benzodiazepines or Zolpidem (Z-Drug) to Controlled-Release Melatonin in Patients With Major Depressive Disorder and Insomnia
Ji Hyun An et al.
FRONTIERS IN PSYCHIATRY (2020)
Antipsychotic Withdrawal Symptoms: A Systematic Review and Meta-Analysis
Lasse Brandt et al.
FRONTIERS IN PSYCHIATRY (2020)
A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based?
James Davies et al.
ADDICTIVE BEHAVIORS (2019)
Psychosocial intervention for discontinuing benzodiazepine hypnotics in patients with chronic insomnia: A systematic review and meta-analysis
Yoshikazu Takaesu et al.
SLEEP MEDICINE REVIEWS (2019)
Dependence, withdrawal and rebound of CNS drugs: an update and regulatory considerations for new drugs development
Alicja Lerner et al.
BRAIN COMMUNICATIONS (2019)
Cognitive Behavioral Therapy for Insomnia Reduces Hypnotic Prescriptions
Kyung Mee Park et al.
PSYCHIATRY INVESTIGATION (2018)
Assessment of Switching to Suvorexant versus the Use of Add-on Suvorexant in Combination with Benzodiazepine Receptor Agonists in Insomnia Patients: A Retrospective Study
Masakazu Hatano et al.
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2018)
Insomnia symptoms and their association with workplace productivity: cross-sectional and pre-post intervention analyses from a large multinational manufacturing company
Colin A. Espie et al.
SLEEP HEALTH (2018)
A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people
Emily Reeve et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline
Michael J. Sateia et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2017)
European guideline for the diagnosis and treatment of insomnia
Dieter Riemann et al.
JOURNAL OF SLEEP RESEARCH (2017)
Efficacy and Safety of 6-Month Nightly Ramelteon Administration in Adults with Chronic Primary Insomnia
SLEEP (2017)
Suvorexant in Elderly Patients with Insomnia: Pooled Analyses of Data from Phase III Randomized Controlled Clinical Trials
W. Joseph Herring et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2017)
Trends in prescribing of sedative-hypnotic medications in the USA: 1993-2010
Christopher N. Kaufmann et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2016)
Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials
W. Joseph Herring et al.
BIOLOGICAL PSYCHIATRY (2016)
Diagnosis and Treatment of Insomnia Comorbid with Obstructive Sleep Apnea
Leon Lack et al.
SLEEP MEDICINE CLINICS (2016)
Cognitive Behavioral Therapy for Chronic Insomnia A Systematic Review and Meta-analysis
James M. Trauer et al.
ANNALS OF INTERNAL MEDICINE (2015)
The Effect of Melatonin on Benzodiazepine Discontinuation and Sleep Quality in Adults Attempting to Discontinue Benzodiazepines: A Systematic Review and Meta-Analysis
Angela Wright et al.
DRUGS & AGING (2015)
American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults
Sue Radcliff et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2015)
Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a randomized, 6-week sleep laboratory trial
Neely Ivgy-May et al.
SLEEP MEDICINE (2015)
Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a 2-week randomized outpatient trial
Neely Ivgy-May et al.
SLEEP MEDICINE (2015)
Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review
Andre S. Pollmann et al.
BMC PHARMACOLOGY & TOXICOLOGY (2015)
Comorbid insomnia in patients with chronic pain: a study based on the Swedish quality registry for pain rehabilitation (SQRP)
Peter Alfoldi et al.
DISABILITY AND REHABILITATION (2014)
Risk versus risk: a review of benzodiazepine reduction in older adults
Allison M. Paquin et al.
EXPERT OPINION ON DRUG SAFETY (2014)
Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial
David Michelson et al.
LANCET NEUROLOGY (2014)
Trends in Outpatient Visits for Insomnia, Sleep Apnea, and Prescriptions for Sleep Medications among US Adults: Findings from the National Ambulatory Medical Care Survey 1999-2010
Earl S. Ford et al.
SLEEP (2014)
National Use of Prescription Medications for Insomnia: NHANES 1999-2010
Suzanne M. Bertisch et al.
SLEEP (2014)
Zolpidem abuse and dependency in an elderly patient with major depressive disorder: a case report
Maryam Pourshams et al.
DARU-JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study
Timothy A. Roehrs et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Patients with insomnia and subthreshold depression show marked worsening of insomnia after discontinuation of sleep promoting medication
Adam Wichniak et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Long-term safety and efficacy of ramelteon in Japanese patients with chronic insomnia
Makoto Uchiyama et al.
SLEEP MEDICINE (2011)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Effect of Eszopiclone 2 mg on Sleep/Wake Function in Older Adults with Primary and Comorbid Insomnia
Sonia Ancoli-Israel et al.
SLEEP (2010)
Comparative Tolerability of Newer Agents for Insomnia
Gary Zammit
DRUG SAFETY (2009)
A typology of reviews: an analysis of 14 review types and associated methodologies
Maria J. Grant et al.
HEALTH INFORMATION AND LIBRARIES JOURNAL (2009)
Efficacy and safety of zolpidem extended release in elderly primary insomnia patients
James K. Walsh et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2008)
Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder
Mark Pollack et al.
ARCHIVES OF GENERAL PSYCHIATRY (2008)
Hypnotic discontinuation in chronic insomnia: Impact of psychological distress, readiness to change, and self-efficacy
Genevieve Belleville et al.
HEALTH PSYCHOLOGY (2008)
Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia
Thomas Roth et al.
SLEEP MEDICINE (2006)
Epidemiology of insomnia:: Prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors
CM Morin et al.
SLEEP MEDICINE (2006)
Quetiapine discontinuation syndrome
DR Kim et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Long-term use of sedative hypnotics in older patients with insomnia
S Ancoli-Israel et al.
SLEEP MEDICINE (2005)
Trimipramine in primary insomnia:: Results of a polysomnographic double-blind controlled study
D Riemann et al.
PHARMACOPSYCHIATRY (2002)
A double-blind, randomized and placebo-controlled study on the polysomnographic withdrawal effects of zopiclone, zolpidem and triazolam in healthy subjects
U Voderholzer et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2001)
Doxepin in the treatment of primary insomnia:: A placebo-controlled, double-blind, polysomnographic study
G Hajak et al.
JOURNAL OF CLINICAL PSYCHIATRY (2001)
Zaleplon improves sleep without producing rebound effects in outpatients with insomnia
J Fry et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2000)
分享论文
